Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | President, Global Limb Recon | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 50,919 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 150 · Balance 50,919 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F2: Includes 36,028 previously reported restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
F2: Includes 36,028 previously reported restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Wright Medical Group N.V.
Report date November 11, 2020 · Filed November 13, 2020
Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 19,586 |
Reported balance
After 2020-11-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-11 · Other · Disposed 31,951 · Balance 19,586 F1: On November 4, 2019, Wright Medical Group N.V. (the "Issuer") entered into a purchase agreement (the "Purchase Agreement") with Stryker Corporation and its subsidiary, Stryker B.V. (the "Purchaser"). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share ("Shares"), of the Issuer (the "Offer"), and, on November 11, 2020 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 31,951 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement). F2: Includes 6,843 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, "Wright RSUs") and 12,743 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the "2020 RSUs"). See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer. |
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 7,821 |
Reported balance
After 2020-11-11 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-11-11 · Disposition to issuer · Disposed 11,765 · Balance 7,821 F3: Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration. See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer. F4: Includes 6,843 Shares issuable upon vesting of the Wright RSUs and 978 Shares issuable upon vesting of the 2020 RSUs. See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer. |
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2020-11-11 · Disposition to issuer · Disposed 7,821 · Balance 0 F5: See Exhibit 99.1. |
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 18,506 |
Reported balance
After 2020-11-11 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2020-11-11 · Grant · Acquired 18,506 · Balance 18,506 F6: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes. |
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2020-11-11 · Disposition to issuer · Disposed 18,506 · Balance 0 F6: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.84 · Expires 2029-07-26 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-11 · Disposition to issuer · Disposed 14,385 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.49 · Expires 2028-07-24 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-11-11 · Disposition to issuer · Disposed 12,278 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.86 · Expires 2027-07-25 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-11 · Disposition to issuer · Disposed 12,363 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.24 · Expires 2026-07-19 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-11 · Disposition to issuer · Disposed 23,897 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.62 · Expires 2025-10-13 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-11-11 · Disposition to issuer · Disposed 13,217 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.62 · Expires 2025-10-13 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-11-11 · Disposition to issuer · Disposed 13,217 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.06 · Expires 2024-05-13 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-11-11 · Disposition to issuer · Disposed 6,113 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.93 · Expires 2023-05-14 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-11-11 · Disposition to issuer · Disposed 6,588 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.75 · Expires 2022-05-09 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2020-11-11 · Disposition to issuer · Disposed 828 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.04 · Expires 2021-05-11 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2020-11-11 · Disposition to issuer · Disposed 3,760 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 4, 2019, Wright Medical Group N.V. (the "Issuer") entered into a purchase agreement (the "Purchase Agreement") with Stryker Corporation and its subsidiary, Stryker B.V. (the "Purchaser"). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share ("Shares"), of the Issuer (the "Offer"), and, on November 11, 2020 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 31,951 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).
F2: Includes 6,843 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, "Wright RSUs") and 12,743 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the "2020 RSUs"). See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer.
F3: Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration. See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer.
F4: Includes 6,843 Shares issuable upon vesting of the Wright RSUs and 978 Shares issuable upon vesting of the 2020 RSUs. See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer.
F5: See Exhibit 99.1.
F6: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes.
F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 150 | $9.44 | $1,416.00 |
DisclosureSEC source: 0001193125-26-414164 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,919 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F2 · balance_after: Includes 36,028 previously reported restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:41 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 150 | $9.39 | $1,408.50 |
DisclosureSEC source: 0001193125-26-381992 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,069 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F2 · balance_after: Includes 36,028 previously reported restricted stock units. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 21:03 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,295 | $10.09 | $13,066.55 |
DisclosureSEC source: 0001193125-26-359362 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,219 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 36,028 previously reported restricted stock units and 1,881 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:17 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 758 | $12.55 | $9,513.51 |
DisclosureSEC source: 0001193125-26-096579 · ownership.xml · nonDerivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,633 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive. F3 · balance_after: Includes 41,134 previously reported restricted stock units Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:17 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 778 | $12.92 | $10,048.88 |
DisclosureSEC source: 0001193125-26-096579 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,391 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · balance_after: Includes 41,134 previously reported restricted stock units Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:48 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,101 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0001193125-26-094459 · ownership.xml · derivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,101 Underlying: Common Stock · 50,101 shares Expires 2033-03-03 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:48 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 21,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-094459 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Limb Recon 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,169 F1 · shares: Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date. F2 · balance_after: Includes 24,936 previously reported restricted stock units and 948 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 20:08 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,996 | $14.21 | $28,363.16 |
DisclosureSEC source: 0001677842-25-000005 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Orthopedics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,116 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 24,936 previously reported restricted stock units and 2,070 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:18 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 34,924 | $0.00 Strike: $16.98 | $0.00 |
DisclosureSEC source: 0000950170-25-033612 · ownership.xml · derivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Global Orthopedics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,924 Underlying: Common Stock · 34,924 shares Expires 2032-03-03 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:18 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,723 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-033612 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Orthopedics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,042 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. F2 · balance_after: Includes 15,319 previously reported restricted stock units. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:25 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 35,195 | $0.00 Strike: $16.32 | $0.00 |
DisclosureSEC source: 0000950170-24-098561 · ownership.xml · derivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Global Orthopedics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,195 Underlying: Common Stock · 35,195 shares Expires 2031-08-15 F2 · derivative.exercise_date: The options shall vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date on which the average closing price of the Company's common stock over a consecutive thirty (30) calendar day period has been equal to or greater than 150% of the option price or (ii) with respect to one-third (1/3rd) of the shares of Stock covered hereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares of Stock covered hereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:25 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 15,319 | $16.32 | $250,006.08 |
DisclosureSEC source: 0000950170-24-098561 · ownership.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Global Orthopedics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,319 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 3,760 | Not disclosed Strike: $15.04 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 15 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,760 shares Expires 2021-05-11 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 828 | Not disclosed Strike: $20.75 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 14 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 828 shares Expires 2022-05-09 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 6,588 | Not disclosed Strike: $23.93 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 13 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,588 shares Expires 2023-05-14 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 6,113 | Not disclosed Strike: $29.06 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 12 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,113 shares Expires 2024-05-13 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 13,217 | Not disclosed Strike: $20.62 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 11 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,217 shares Expires 2025-10-13 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 13,217 | Not disclosed Strike: $20.62 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 10 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,217 shares Expires 2025-10-13 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 23,897 | Not disclosed Strike: $21.24 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 9 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 23,897 shares Expires 2026-07-19 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 12,363 | Not disclosed Strike: $27.86 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 8 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,363 shares Expires 2027-07-25 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 12,278 | Not disclosed Strike: $24.49 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 7 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,278 shares Expires 2028-07-24 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 14,385 | Not disclosed Strike: $27.84 | Not disclosed |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · derivative · entry 6 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,385 shares Expires 2029-07-26 F7 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F7 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerOrdinary Shares, par value EUR 0.03 per share | 18,506 | $30.75 | $569,059.50 |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · nonDerivative · entry 5 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F6 · kind: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 18,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · nonDerivative · entry 4 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,506 F6 · kind: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerOrdinary Shares, par value EUR 0.03 per share | 7,821 | $30.75 | $240,495.75 |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · nonDerivative · entry 3 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · kind: See Exhibit 99.1. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerOrdinary Shares, par value EUR 0.03 per share | 11,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · nonDerivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,821 F3 · shares: Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration. See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer. F4 · balance_after: Includes 6,843 Shares issuable upon vesting of the Wright RSUs and 978 Shares issuable upon vesting of the 2020 RSUs. See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 18:23 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | OtherOrdinary Shares, par value EUR 0.03 per share | 31,951 | $30.75 | $982,493.25 |
DisclosureSEC source: 0001686266-20-000017 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,586 F1 · kind: On November 4, 2019, Wright Medical Group N.V. (the "Issuer") entered into a purchase agreement (the "Purchase Agreement") with Stryker Corporation and its subsidiary, Stryker B.V. (the "Purchaser"). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share ("Shares"), of the Issuer (the "Offer"), and, on November 11, 2020 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 31,951 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement). F2 · balance_after: Includes 6,843 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, "Wright RSUs") and 12,743 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the "2020 RSUs"). See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 16:41 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 1,261 | $30.14 | $38,007.04 |
DisclosureSEC source: 0001235802-20-000110 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,537 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.14 to $30.145, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 3,335 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 16,251 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 16:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 12,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000091 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,798 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The grant agreement contemplates that the shares will vest pro rata through the closing of the previously announced Stryker transaction, and shares unvested at closing will be cancelled. F2 · balance_after: Includes 5,526 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,420 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 17:17 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 3,129 | $29.55 | $92,462.26 |
DisclosureSEC source: 0001235802-20-000069 · primary_doc.xml · nonDerivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,055 F3 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of performance share unit awards. F2 · balance_after: Includes 5,526 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,677 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 17:17 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 8,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000069 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,184 F1 · shares: Represents the payout of a performance share unit award for the June 26, 2017 - June 28, 2020 performance period under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, as approved by the Issuer's Compensation Committee of its Board of Directors. Performance share unit awards are paid in ordinary shares of the Issuer. F2 · balance_after: Includes 5,526 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,677 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 16:42 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 770 | $29.76 | $22,915.28 |
DisclosureSEC source: 0001235802-20-000060 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,808 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 5,526 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,677 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 16:38 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 828 | $21.01 | $17,400.25 |
DisclosureSEC source: 0001235802-19-000114 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,578 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 2,079 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,526 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,677 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:13 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantStock Option (right to buy) · Derivative | 14,385 | $0.00 Strike: $27.84 | $0.00 |
DisclosureSEC source: 0001235802-19-000086 · primary_doc.xml · derivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,385 Underlying: Ordinary Shares · 14,385 shares Expires 2029-07-26 F3 · derivative.exercise_date: This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:13 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 4,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000086 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,406 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. F2 · balance_after: Includes 2,079 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 7,717 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, 4,677 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan and 934 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 16:42 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 1,656 | $30.78 | $50,976.32 |
DisclosureSEC source: 0001235802-19-000051 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,569 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.75 to $30.87, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 2,079 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 7,717 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 774 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 16:25 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GiftOrdinary Shares, par value EUR 0.03 per share | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-18-000186 · primary_doc.xml · nonDerivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,064 F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 7,717 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 16:25 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 9,000 | $27.62 | $248,617.80 |
DisclosureSEC source: 0001235802-18-000186 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,064 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.59 to $27.67, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 7,717 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| September 10, 2018 Filed Sep 11, 2018 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $27.90 | $2,790.00 |
DisclosureSEC source: 0001235802-18-000143 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,064 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 7,717 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 16:50 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 405 | $27.14 | $10,993.64 |
DisclosureSEC source: 0001235802-18-000131 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,164 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 7,717 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 16:04 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $27.99 | $2,799.00 |
DisclosureSEC source: 0001235802-18-000121 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,569 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 8,764 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 16:54 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantStock Option (right to buy) · Derivative | 12,278 | $0.00 Strike: $24.49 | $0.00 |
DisclosureSEC source: 0001235802-18-000111 · primary_doc.xml · derivative · entry 2 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,278 Underlying: Ordinary Shares · 12,278 shares Expires 2028-07-24 F3 · derivative.exercise_date: This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 16:54 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 4,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-18-000111 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,669 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 8,764 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 16:30 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $25.44 | $2,544.00 |
DisclosureSEC source: 0001235802-18-000095 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,093 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 613 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 16:13 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $24.95 | $2,495.00 |
DisclosureSEC source: 0001235802-18-000081 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,014 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 434 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 16:25 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 1,662 | $24.63 | $40,935.06 |
DisclosureSEC source: 0001235802-18-000075 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,114 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.51 to $24.84, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 6,442 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 434 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| May 10, 2018 Filed May 10, 2018 17:20 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $23.49 | $2,349.00 |
DisclosureSEC source: 0001235802-18-000066 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,776 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 10,805 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 434 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| April 12, 2018 Filed Apr 16, 2018 16:04 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $20.24 | $2,024.00 |
DisclosureSEC source: 0001235802-18-000050 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,876 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 10,805 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 434 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 16:27 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $20.72 | $2,072.00 |
DisclosureSEC source: 0001235802-18-000038 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,976 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 10,805 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 434 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 16:37 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 100 | $20.14 | $2,014.00 |
DisclosureSEC source: 0001235802-18-000016 · primary_doc.xml · nonDerivative · entry 1 Fisher Patrick · CIK 0001677842 · President, Lower Extremities 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,076 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 10,805 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 4,188 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 434 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.